Advertisement
YOU ARE HERE: LAT HomeCollectionsPlatelets
IN THE NEWS

Platelets

BUSINESS
March 17, 2000 | Dow Jones
Nexell Therapeutics Inc.'s surging stock moved up another 12% Thursday after the Irvine cancer research company said it received a patent covering in-vitro growth of specialized white blood cells to help the immune system fight bacterial infection and produce platelets to support blood clotting. The stock, which has gained 700% so far this year, closed at $10 a share, up $1.09, in Nasdaq trading.
Advertisement
NEWS
May 21, 1988 | Clipboard researched by Rick VanderKnyff / Los Angeles Times
Only about 20% of all the blood Red Cross collects is used as whole blood, which has a shelf life of 42 days. These are the major blood products: RED CELLS are used for about 70% of all blood needs. Shelf life: 42 days (Can also be frozen and stored for three years, but once reconstituted they must be used within 24 hours. The freezing-reconstituting process is costly and is used primarily for preservation of rare blood.) Diameter: 7 microns (1 micron=0.
BUSINESS
July 16, 1991
HemaCare Corp., a Sherman Oaks company that sells blood-related products and services, said that earlier this month it received licenses from the Food and Drug Administration that allow HemaCare to begin selling some new types of blood products. It said licenses were also granted by the FDA that allow the company to sell some of its existing products outside California for the first time. A total of six licenses were granted by the federal agency.
CALIFORNIA | LOCAL
August 1, 1989
Scientific and political controversies have coincided in Sacramento to postpone, and perhaps kill, legislation to extend the use of paid donors of blood platelets, which are small cells used in several types of surgery. The subject is too serious to dismiss in this way. The problem is complex. Platelets are in short supply. The Red Cross Blood Bank serving Los Angeles and Orange counties estimates the demand at 40,000 units a year.
CALIFORNIA | LOCAL
February 2, 2012 | By Anna Gorman, Los Angeles Times
Christina Blouvan-Cervantes had been battling aggressive leukemia when her blood count plummeted and she landed in the emergency room in Fresno. Her doctors told her a blood transfusion was her only hope. But her faith wouldn't allow her to receive one. So she turned to one of the only doctors who could possibly keep her alive: a committed atheist who views her belief system as wholly irrational. Dr. Michael Lill, head of the blood and marrow transplant program at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute, is a last recourse for Jehovah's Witnesses with advanced leukemia.
BUSINESS
April 15, 2007 | Daniel Costello, Times Staff Writer
Kevin Sharer has a thing for maverick war heroes. In his sunlit office in Thousand Oaks, a massive portrait of the often-flamboyant Gen. George Armstrong Custer hangs across from his desk. It complements one of English naval great Horatio Nelson, renowned for defying orders. Sharer has a military background himself, gained as an engineer on fast-attack Navy nuclear submarines during the Cold War. These days, at troubled Amgen Inc., he's emulating his risk-taking heroes more than ever.
BUSINESS
June 21, 1994
Amgen Inc., the Thousand Oaks biotechnology giant, agreed to jointly develop a treatment for cancer patients undergoing chemotherapy with Japanese beer company Kirin Brewery Co. Amgen and Kirin, which has a pharmaceutical division, are longtime research and marketing partners for Amgen's two blockbuster drugs, Epogen and Neupogen.
CALIFORNIA | LOCAL
September 16, 1989 | JACK CHEEVERS, Times Staff Writer
The state Senate gave final legislative approval Friday to a bill to continue allowing the sale of a special blood product from paid donors, a law that would benefit a Sherman Oaks firm with ties to co-sponsor Assemblyman Tom Bane. The legislation, approved unanimously without discussion, would renew for three years an exemption from a state law that bans the sale of blood products from paid donors. HemaCare Corp.
CALIFORNIA | LOCAL
September 19, 1998
The Los Angeles area is experiencing a critical blood shortage, which has diminished the supply of types B and O blood throughout Southern California, the American Red Cross said this week. The supply of both O positive and O negative blood and blood platelets has reached crisis levels, said Rich Krieg, of the Red Cross Blood Services Southern California Region. In addition to type B blood, there is a particular need for type O blood. Information: (800) GIVE-LIFE.
Los Angeles Times Articles
|